We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

This study has been terminated.
(Program was terminated for business reasons)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01295060
First Posted: February 14, 2011
Last Update Posted: September 20, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Endo Pharmaceuticals
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: September 9, 2013